Deep Track Capital »

Agenus shares owned by Deep Track Capital

Quarter-by-quarter ownership of Agenus (AGEN) shares owned by Deep Track Capital from 13F filings

Historical chart of Deep Track Capital investment in Agenus

Tip: Access up to 7 years of quarterly data

All positions including Agenus held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Agenus by Deep Track Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.2M 313k 16.75

More positions owned by Deep Track Capital

Amgen (AMGN)
Argenx Se Sponsored Adr (ARGX)
Axsome Therapeutics (AXSM)
Dyne Therapeutics (DYN)
Springworks Therapeutics (SWTX)
Insmed Com Par $.01 (INSM)
Guardant Health (GH)
Dynavax Technologies Corp Com New (DVAX)
Alnylam Pharmaceuticals (ALNY)
Intellia Therapeutics (NTLA)
Intra Cellular Therapies (ITCI)
Apellis Pharmaceuticals (APLS)
Ionis Pharmaceuticals (IONS)
Ocular Therapeutix (OCUL)
4d Molecular Therapeutics In (FDMT)

View all positions for Deep Track Capital

Top funds holding Agenus

Vanguard Group
BlackRock
BlackRock
Siren
Susquehanna International
Geode Capital Management
State Street Corporation
Morgan Stanley
Deep Track Capital
Federated Investors
Northern Trust
Renaissance Technologies
Citadel Advisors
ExodusPoint Capital Management
Bank of America Corporation

View all funds holding Agenus